Apoptosis
Antigen presentation pathways contribute differentially to vaccinia virus immunogenicity
Published in Vaccine Weekly, October 25th, 2006
According to a study from the United States, "Modified vaccinia virus Ankara (MVA) is an attenuated strain of vaccinia virus (VV) that has attracted significant attention as a candidate viral vector vaccine for immunization against infectious diseases and treatment of malignancies.
"Although MVA is unable to replicate in most nonavian cells, vaccination with MVA elicits immune responses that approximate those seen after the administration of replication-competent strains of VV. However, the mechanisms by which these viruses...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-10-25)
More Articles from Vaccine Weekly
- Cholera Vaccine
Double mutant cholera toxin adjuvants have enhanced immunity without CNS toxicity - Ebola Virus Vaccine
Adenoviral vaccine vector protects against lethal Ebola virus - Influenza Vaccine
ELISpot assay detects cellular immunity after flu vaccine in kidney transplant recipients - Acute Myelogenous Leukemia
Juvaris wins innovation research grant for acute myelogenous leukemia vaccine development - Adenovirus Vector
Adenoviral vectors encoding bone morphogenetic protein-2 retarded bone formation - Adenovirus Vector
Gene therapy increases survival in glycogen storage disease type Ia - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
